Detalhe da pesquisa
1.
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
J Immunol
; 211(3): 351-364, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326480
2.
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.
J Immunol
; 208(2): 429-443, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903642
3.
Iddm30 controls pancreatic expression of Ccl11 (Eotaxin) and the Th1/Th2 balance within the insulitic lesions.
J Immunol
; 192(8): 3645-53, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24646746
4.
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity.
Mucosal Immunol
; 17(2): 201-210, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278415
5.
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection.
Mucosal Immunol
; 15(5): 799-808, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468942
6.
Type 1 diabetes in the BB rat: a polygenic disease.
Diabetes
; 58(4): 1007-17, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19168599